Search

What we do

Our consultancy activities with the pharmaceutical companies focuses on research and the creation of a certain balance.
Our goal is to be on an equal footing with our clients, and to be able to offer different perspectives freely, including negative scenarios.
Our area of expertise covers medications for human use in classification, reimbursement and access at a national level. We specialise in innovative, orphan and oncology medicines strategies.
We devote ourselves to our projects, establishing trust relationships with our clients and striving to find a common ground with the institutions by offering original strategies.

To learn about the values and principles which form the foundation of the identity and daily practice of Pharma Value and its people, read our Code of ethics.

Over time, we have become consultants to medium-small companies and start-ups, some of which have grown together with us. On a national level, we have also played a role in the launch of effective and/or innovative medicines that address, until now, unmet clinical needs of patients.

Our Regulatory Business activities aimed at national access include:

Medicines regulatory monitoring

Regulatory analysis

Scenario assessments

Institutional relations

Competitor analysis

Corporate training

en_GB